iFabric Launches Scrubs Program at Major US Retailer
iFabric (OTCQX:IFABF) announced that its subsidiary Intelligent Fabric Technologies (North America) Inc. has begun the launch of Doctor's Choice Next Generation scrubs with an initial rollout at a leading U.S. national big-box retailer. The first collections integrate IFTNA flagship technologies: PROTX2 (advanced antimicrobial), ecoPEL (C0 PFC-free DWR), and DryTX (moisture management).
Collections will launch online first, with in-store availability expected at the end of October 2025. Product claims include clinically proven antimicrobial finish, PFC-free water repellency, and wicking/quick-dry performance designed for clinical use.
iFabric (OTCQX:IFABF) ha annunciato che la sua controllata Intelligent Fabric Technologies (North America) Inc. ha iniziato il lancio di Doctor's Choice Next Generation scrubs con un rollout iniziale presso un importante retailer americano nazionale di grandi dimensioni. Le prime collezioni integrano le tecnologie di punta di IFTNA: PROTX2 (antimicrobico avanzato), ecoPEL (DWR privo di PFC) e DryTX (gestione dell'umidità).
Le collezioni saranno lanciate online prima, con disponibilità in negozio prevista entro la fine di ottobre 2025. Le affermazioni sui prodotti includono una finitura antimicrobica clinicamente testata, idrorepellenza priva di PFC e prestazioni di assorbimento/asciugatura rapida progettate per uso clinico.
iFabric (OTCQX:IFABF) anunció que su subsidiaria Intelligent Fabric Technologies (North America) Inc. ha comenzado el lanzamiento de Doctor's Choice Next Generation scrubs con un despliegue inicial en un importante minorista nacional de gran formato en Estados Unidos. Las primeras colecciones integran las tecnologías insignia de IFTNA: PROTX2 (antimicrobiano avanzado), ecoPEL (DWR sin PFC), y DryTX (gestión de la humedad).
Las colecciones se lanzarán primero en línea, y la disponibilidad en tiendas se espera para finales de octubre de 2025. Las afirmaciones de producto incluyen un acabado antimicrobiano clínicamente probado, repelencia de agua sin PFC y rendimiento de absorción/secar rápido diseñado para uso clínico.
iFabric (OTCQX:IFABF)는 자회사 Intelligent Fabric Technologies (North America) Inc.가 Doctor's Choice Next Generation 스크럽을 미국의 주요 대형 소매업체에서 초기 롤아웃으로 시작했다고 발표했습니다. 첫 컬렉션은 IFTNA의 주력 기술인 PROTX2 (첨단 항균), ecoPEL (C0 PF C-free DWR), 그리고 DryTX (수분 관리)를 통합합니다.
컬렉션은 먼저 온라인으로 출시되며 매장 내 구입은 2025년 10월 말에 예정되어 있습니다. 제품 주장은 임상적으로 입증된 항균 마감, PF C-free 발수성, 빠른 흡수/건조 성능이 임상 사용을 위해 설계되었다는 내용입니다.
iFabric (OTCQX:IFABF) a annoncé que sa filiale Intelligent Fabric Technologies (North America) Inc. a commencé le lancement des vêtements professionnels Doctor's Choice Next Generation avec un déploiement initial chez un important détaillant national américain de grande enseigne. Les premières collections intègrent les technologies phares d'IFTNA: PROTX2 (antimicrobien avancé), ecoPEL (DWR sans PFC), et DryTX (gestion de l'humidité).
Les collections seront lancées d'abord en ligne, avec une disponibilité en magasin prévue d'ici la fin du octobre 2025. Les allégations produit incluent une finition antimicrobienne cliniquement prouvée, une répulsion de l'eau sans PFC et une performance d'absorption/séchage rapide conçue pour un usage clinique.
iFabric (OTCQX:IFABF) gab bekannt, dass seine Tochtergesellschaft Intelligent Fabric Technologies (North America) Inc. mit dem Start der Doctor's Choice Next Generation Scrubs begonnen hat, mit einem ersten Rollout bei einem führenden nationalen Großhändler in den USA. Die ersten Kollektionen integrieren die Flaggschiff-Technologien von IFTNA: PROTX2 (fortschrittliche antimikrobielle Wirkung), ecoPEL (PFC-freier DWR) und DryTX (Feuchtigkeitsmanagement).
Die Kollektionen werden zunächst online eingeführt, die Verfügbarkeit im Geschäft wird Ende Oktober 2025 erwartet. Produktbehauptungen umfassen eine klinisch nachgewiesene antimikrobielle Oberfläche, PF C-freien Wasserabweis und Feuchtigkeitsableitung/Schnelltrocknung, konzipiert für den klinischen Einsatz.
iFabric (OTCQX:IFABF) أعلنت أن شركتها التابعة Intelligent Fabric Technologies (North America) Inc. قد بدأت في إطلاق Doctor's Choice Next Generation البدلات الطبية مع طرح أولي لدى تاجر تجزئة رئيسي أمريكي كبير. تجمع المجموعة الأولى تقنيات IFTNA الرائدة: PROTX2 (مضاد ميكروبي متقدم)، ecoPEL (DWR خالٍ من PFCS)، وDryTX (إدارة الرطوبة).
سيتم إطلاق المجموعات عبر الإنترنت أولاً، مع توفرها في المتاجر المقرر بنهاية أكتوبر 2025. تشمل ادعاءات المنتج تغليفًا مضادًا للميكروبات مثبتًا سريريًا، ومقاومة للماء بدون PFCS، وأداء امتصاص/جفاف سريع مصمم للاستخدام الطبي.
iFabric (OTCQX:IFABF) 宣布其子公司 Intelligent Fabric Technologies (North America) Inc. 已开始推出 Doctor's Choice Next Generation 医用工作服，在美国一家领先的全国性大型零售商启动初步上线。第一批系列整合了 IFTNA 的旗舰技术：PROTX2（先进抗菌）、ecoPEL（无 C0 PF C 的防水剂）以及 DryTX（湿度管理）。
系列产品将先在线上发售，预计在 2025年10月末在实体店有售。产品声称包括经临床验证的抗菌处理、无 PFCS 的防水性能，以及为临床使用设计的快干/排汗性能。
- Initial rollout at a leading U.S. national big-box retailer
- Collections combine PROTX2, ecoPEL, and DryTX technologies
- In-store availability scheduled for end of October 2025
- None.
MARKHAM, ON, ON / ACCESS Newswire / October 15, 2025 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF) announces that its wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has begun the launch of Doctor's Choice® Next Generation scrubs with an initial rollout at a leading U.S. national big-box retailer.
The first collections will integrate three of IFTNA's flagship textile technologies, combining PROTX2® (advanced antimicrobial) with ecoPEL® (C0 PFC-free durable water repellent), and PROTX2® (advanced antimicrobial) with DryTX™ (moisture-management); delivering two performance scrub platforms designed for everyday clinical demands. These fabric treatments are targeted to provide scrubs that are cleaner, safer, and more comfortable, with these benefits expected to last through the life of the scrubs. The first collections will initially launch online, with instore availability at the end of October 2025. The following is a link to one of the items in the range:
"Doctor's Choice Next Generation scrubs are built to give healthcare professionals reliable, lab-tested performance where it matters most," said Giancarlo Beevis, President & CEO of IFTNA. "By combining PROTX2 with ecoPEL, and PROTX2 with DryTX, we're helping set a new benchmark for comfort, protection, and durability in medical apparel," concluded Mr. Beevis.
Collection Highlights
PROTX2® Antimicrobial: Clinically proven anti-microbial performance finish.
ecoPEL® DWR: C0, PFC-free water repellency to help resist fluid penetration while supporting environmental sustainability goals.
DryTX™ Moisture Management: Wicking and quick-dry properties to enhance all-shift comfort and breathability.
Designed for Care: Soft-hand feel, stretch options, and utility pocketing; styles and fits tailored for clinical workflow.
The launch underscores IFTNA's strategy to broaden adoption of it's technologies across high-use uniform categories, pairing evidence-driven finishes with mass-market accessibility through the retailer's nationwide footprint.
About iFabric Corp.
iFabric Corp. (TSX:IFA)(OTCQX:IFABF) develops, licenses, and commercializes innovative performance technologies for textiles and apparel. Through its Intelligent Fabric Technologies (North America) division, iFabric partners with global brands and retailers to deliver enhanced functionality-ranging from antimicrobial and moisture management to PFAS-free water repellency-across diverse end uses. For more information, visit www.ifabriccorp.com.
About IFTNA
Intelligent Fabric Technologies (North America) Inc., a wholly owned subsidiary of iFabric Corp., engineers and supplies proprietary chemistries-including PROTX2®, ecoPEL®, and DryTX™ to elevate textile performance in consumer, medical, and industrial markets.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding the referenced products, product launches, market adoption, and anticipated performance features. Forward-looking statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially. iFabric undertakes no obligation to update forward-looking statements except as required by law.
FOR FURTHER INFORMATION PLEASE CONTACT:
Hylton Karon, President & CEO | Giancarlo Beevis, COO | Hilton Price, CFO |
Website: www.ifabriccorp.com
Neither the TSX Exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this press release.
SOURCE: iFabric Corp
View the original press release on ACCESS Newswire
FAQ
When will iFabric (IFABF) Doctor's Choice Next Generation scrubs be available in stores?
What technologies are included in iFabric (IFABF) Doctor's Choice Next Generation scrubs?
Which retailer is carrying iFabric (IFABF) Doctor's Choice scrubs online at launch?
What performance benefits does iFabric (IFABF) claim for the new scrub collections?
Who is leading the rollout of the Doctor's Choice Next Generation scrubs for iFabric (IFABF)?
